Teva Pharmaceutical Industries Limited
TEVA
Price:
$28.41
Market Cap:
$32.54B
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system include Copaxone for the treat...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
1982-02-16
Stock Exchange
NYSE
Ticker
TEVA
PE Ratio
[46.57]
ROE
[-2.58%]
Current Ratio
[1.06]
Dividend Yield
[0%]
Enterprise Value
[47.90B]
Dividend History
The ROE as of December 2025 (TTM) for Teva Pharmaceutical Industries Limited (TEVA) is -2.58%
According to Teva Pharmaceutical Industries Limited’s latest financial reports and current stock price. The company's current ROE is -2.58%. This represents a change of 178.88% compared to the average of -0.92% of the last 4 quarters.
Teva Pharmaceutical Industries Limited (TEVA) Historical ROE (quarterly & annually)
How has TEVA ROE performed in the past?
The mean historical ROE of Teva Pharmaceutical Industries Limited over the last ten years is -21.26%. The current -2.58% ROE has changed -87.88% with respect to the historical average. Over the past ten years (40 quarters), TEVA's ROE was at its highest in in the December 2023 quarter at 5.72%. The ROE was at its lowest in in the December 2017 quarter at -66.45%.
Average
-21.26%
Median
-11.03%
Minimum
-93.70%
Maximum
5.33%
Teva Pharmaceutical Industries Limited (TEVA) ROE by Quarter and Year
Discovering the peaks and valleys of Teva Pharmaceutical Industries Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 456.59%
Maximum Annual ROE = 5.33%
Minimum Annual Increase = -9594.24%
Minimum Annual ROE = -93.70%
| Year | ROE | Change |
|---|---|---|
| 2024 | -30.50% | 309.60% |
| 2023 | -7.45% | -75.01% |
| 2022 | -29.80% | -834.40% |
| 2021 | 4.06% | -110.19% |
| 2020 | -39.80% | 456.59% |
| 2019 | -7.15% | -51.09% |
| 2018 | -14.62% | -84.40% |
| 2017 | -93.70% | -9594.24% |
| 2016 | 0.99% | -81.50% |
| 2015 | 5.33% | -59.29% |
Teva Pharmaceutical Industries Limited (TEVA) Average ROE
How has TEVA ROE performed in the past?
The current ROE of Teva Pharmaceutical Industries Limited (TEVA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-22.58%
5-year avg
-20.70%
10-year avg
-21.26%
Teva Pharmaceutical Industries Limited (TEVA) ROE vs. Peers
How is TEVA’s ROE compared to its peers?
Teva Pharmaceutical Industries Limited’s ROE is less than Biogen Inc. (9.25%), less than STERIS plc (10.21%), less than DexCom, Inc. (29.82%), greater than BioNTech SE (-1.83%), greater than Natera, Inc. (-25.07%), less than Insulet Corporation (18.27%), less than Labcorp Holdings Inc. (10.20%), less than Waters Corporation (31.34%), less than Koninklijke Philips N.V. (1.41%), less than Neurocrine Biosciences, Inc. (15.82%),
| Company | ROE | Market cap |
|---|---|---|
| 9.25% | $26.70B | |
| 10.21% | $25.68B | |
| 29.82% | $25.53B | |
| -1.83% | $23.08B | |
| -25.07% | $33.41B | |
| 18.27% | $22.22B | |
| 10.20% | $21.68B | |
| 31.34% | $23.60B | |
| 1.41% | $25.35B | |
| 15.82% | $15.33B |
Build a custom stock screener for Teva Pharmaceutical Industries Limited (TEVA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Teva Pharmaceutical Industries Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Teva Pharmaceutical Industries Limited (TEVA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Teva Pharmaceutical Industries Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Teva Pharmaceutical Industries Limited's ROE?
How is the ROE calculated for Teva Pharmaceutical Industries Limited (TEVA)?
What is the highest ROE for Teva Pharmaceutical Industries Limited (TEVA)?
What is the 3-year average ROE for Teva Pharmaceutical Industries Limited (TEVA)?
What is the 5-year average ROE for Teva Pharmaceutical Industries Limited (TEVA)?
How does the current ROE for Teva Pharmaceutical Industries Limited (TEVA) compare to its historical average?